Restricted Mean Survival Time for Survival Analysis: A Quick Guide for Clinical Researchers

被引:30
|
作者
Han, Kyunghwa [1 ,2 ]
Jung, Inkyung [3 ]
机构
[1] Yonsei Univ, Dept Radiol, Res Inst Radiol Sci, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Ctr Clin Imaging Data Sci, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Div Biostat, Dept Biomed Syst Informat, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
Restricted mean survival time; Restricted mean time lost; Hazard ratio; Survival curve; Survival analysis;
D O I
10.3348/kjr.2022.0061
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In radiological research, survival analysis has been increasingly used to evaluate prognostic outcomes [1]. Researchers may be familiar with the use of Cox proportional hazards (PH) regression to quantify the effect of predictors, such as treatment, imaging, or radiological variables, using hazard ratios. Cox regression requires the proportional hazards assumption, which means that the ratio of hazards between groups is constant over the entire study period, to be valid; however, this scenario is rarely achieved with real-world data. In addition, the hazard ratio simply quantifies the relative difference in risk based on a model-based approach; therefore, it is difficult to interpret the absolute effect directly. To overcome these limitations, other types of Cox regression, such as stratified Cox regression or Cox regression with time-varying covariates, or parametric survival models, such as the accelerated failure time model, can be applied; however, these analytical methods still yield hazard ratios as the output. Other traditional options for the output in survival analysis include several model-free summary measures based on survival rate at a given time (e.g., 1-year survival) or percentiles of the survival function (e.g., median survival time). Interestingly, a more simplified and intuitive approach, namely RMST, has been recently proposed as an alternative output in survival analysis to hazard ratio [2]. © 2022 The Korean Society of Radiology.
引用
收藏
页码:495 / 499
页数:5
相关论文
共 50 条
  • [21] Pravastatin for Primary Prevention in Older Adults: Restricted Mean Survival Time Analysis
    Orkaby, Ariela R.
    Rich, Michael W.
    Sun, Ryan
    Lux, Eliah
    Wei, Lee-Jen
    Kim, Dae Hyun
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (10) : 1987 - 1991
  • [22] Analysis of stage III stomach cancer using the restricted mean survival time
    Kim, Bitna
    Lee, Minjung
    [J]. KOREAN JOURNAL OF APPLIED STATISTICS, 2021, 34 (02) : 255 - 266
  • [23] Regression analysis of restricted mean survival time based on pseudo-observations
    Andersen, PK
    Hansen, MG
    Klein, JP
    [J]. LIFETIME DATA ANALYSIS, 2004, 10 (04) : 335 - 350
  • [24] Analysis of dynamic restricted mean survival time based on pseudo-observations
    Yang, Zijing
    Zhang, Chengfeng
    Hou, Yawen
    Chen, Zheng
    [J]. BIOMETRICS, 2023, 79 (04) : 3690 - 3700
  • [25] Regression Analysis of Restricted Mean Survival Time Based on Pseudo-Observations
    Per Kragh Andersen
    Mette Gerster Hansen
    John P. Klein
    [J]. Lifetime Data Analysis, 2004, 10 : 335 - 350
  • [26] A guide to survival analysis for manual therapy clinicians and researchers
    Hancock, Mark J.
    Maher, Christopher G.
    Menezes Costa, Luciola da Cunha
    Williams, Christopher M.
    [J]. MANUAL THERAPY, 2014, 19 (06) : 511 - 516
  • [27] Estimating the treatment effect in a clinical trial using difference in restricted mean survival time
    Royston, Patrick
    [J]. STATA JOURNAL, 2015, 15 (04): : 1098 - 1117
  • [28] Scaling and interpreting treatment effects in clinical trials using restricted mean survival time
    Karrison, Theodore
    Hu, Chen
    Dignam, James
    [J]. CLINICAL TRIALS, 2024,
  • [29] Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studies
    Rivano, Melania
    Cancanelli, Luca
    Di Spazio, Lorenzo
    Chiumente, Marco
    Mengato, Daniele
    Messori, Andrea
    [J]. IMMUNOTHERAPY, 2021, 13 (02) : 95 - 101
  • [30] Semiparametric estimation of restricted mean survival time as a function of restriction time
    Bai, Fangfang
    Yang, Xiaoran
    [J]. STATISTICS IN MEDICINE, 2023, 42 (29) : 5389 - 5404